Description
Learners step into the role of Dr. Elena Rodriguez, CEO of BioPharma Innovations, whose revolutionary cancer immunotherapy, Oncalytica, offers unprecedented remission rates but lacks the resources for global delivery. In this negotiation, students must secure a deal that accelerates worldwide access, protects scientific integrity, and preserves company culture while navigating investor demands and regulatory scrutiny.
Reviews
There are no reviews yet.